Life sciences Life sciences Women’s health biopharmaceutical company ObsEva receives USD 500 million 10 August 2021
Life sciences Life sciences Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million 11 May 2021
Life sciences Calcification propensity diagnostics start-up Calciscon raises CHF 2.5 million 19 April 2021
Business environment Tech4Eva, the first Swiss start-up accelerator addressing women’s health 23 March 2021
Life sciences Bern scientists develop individualized cancer models to predict therapy success 10 March 2021